BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36575101)

  • 1. Is Sentinel Lymph Node Biopsy Necessary in Patients who Undergo Prophylactic Mastectomy?
    Madan V; Mamounas EP
    Clin Breast Cancer; 2023 Feb; 23(2):231-236. PubMed ID: 36575101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
    Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy during prophylactic mastectomy: is there a role?
    Bunting PW; Cyr AE; Gao F; Margenthaler JA
    J Surg Oncol; 2014 Jun; 109(8):747-50. PubMed ID: 24535940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.
    Dupont EL; Kuhn MA; McCann C; Salud C; Spanton JL; Cox CE
    Am J Surg; 2000 Oct; 180(4):274-7. PubMed ID: 11113434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
    Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
    Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations.
    Thompson JL; Sinco BR; McCaffrey RL; Chang AE; Sabel MS; Dossett LA; Hughes TM; Jeruss JS
    J Surg Oncol; 2023 Jan; 127(1):18-27. PubMed ID: 36069388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Cancer and Role of Sentinel Lymph Node Biopsy in BRCA Mutation Carriers Undergoing Prophylactic Mastectomies.
    Fat SC; Weed C; Samaha Y; Chung A; Boyle MK; Giuliano A; Ray E; Amersi F
    Am Surg; 2023 Oct; 89(10):4066-4071. PubMed ID: 37184070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy.
    Laronga C; Lee MC; McGuire KP; Meade T; Carter WB; Hoover S; Cox CE
    J Am Coll Surg; 2009 Dec; 209(6):746-52; quiz 800-1. PubMed ID: 19959044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
    Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
    Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
    Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
    Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B
    Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of breast MRI in high-risk patients with newly diagnosed breast cancer to exclude invasive disease in the contralateral prophylactic mastectomy: Is there a role to choose wisely patients for sentinel node biopsy?
    Freitas V; Crystal P; Kulkarni SR; Ghai S; Bukhanov K; Escallon J; Scaranelo AM
    Cancer Med; 2016 Jun; 5(6):1031-6. PubMed ID: 26992816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.
    Tunon-de-Lara C; Giard S; Buttarelli M; Blanchot J; Classe JM; Baron M; Monnier B; Houvenaeghel G
    Breast J; 2008; 14(2):135-40. PubMed ID: 18315691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sentinel lymph node biopsy in ductal carcinoma-in-situ treated by mastectomy.
    Tan JC; McCready DR; Easson AM; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):638-45. PubMed ID: 17103256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine prophylactic sentinel lymph node biopsy is not indicated in women undergoing prophylactic mastectomy.
    Czyszczon IA; Roland L; Sahoo S
    J Surg Oncol; 2012 Jun; 105(7):650-4. PubMed ID: 22213101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.
    Hotton J; Salleron J; Rauch P; Buhler J; Pierret M; Baumard F; Leufflen L; Marchal F
    J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101641. PubMed ID: 31562936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.